Anemia Control in Kidney Transplant Recipients Using Once-Monthly Continuous Erythropoietin Receptor Activator: A Prospective, Observational Study

In a multicenter, prospective, observational study of 279 kidney transplant recipients with anemia, the efficacy and safety of once-monthly continuous erythropoietin receptor activator (C.E.R.A.) were assessed to a maximum of 15 months. The main efficacy variable was the proportion of patients achie...

Descripción completa

Detalles Bibliográficos
Autores principales: Budde, Klemens, Rath, Thomas, Kliem, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026977/
https://www.ncbi.nlm.nih.gov/pubmed/24883202
http://dx.doi.org/10.1155/2014/179705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026977/
https://www.ncbi.nlm.nih.gov/pubmed/24883202
http://dx.doi.org/10.1155/2014/179705

Ejemplares similares